Cargando…

Laying the ground for research of interstitial lung disease in our country: ILD India registry

Detalles Bibliográficos
Autores principales:	Singh, Virendra, Sharma, Bharat Bhushan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220311/ https://www.ncbi.nlm.nih.gov/pubmed/25378837 http://dx.doi.org/10.4103/0970-2113.142091

Ejemplares similares

Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry
por: Raghu, Ganesh, et al.
Publicado: (2016)

Survival predictors of interstitial lung disease in India: Follow-up of Interstitial Lung Disease India registry
por: Singh, Sheetu, et al.
Publicado: (2021)

Publication process at Lung India: Some FAQs and the editorial perspective
por: Singh, Virendra, et al.
Publicado: (2013)

ChILD – Children's interstitial lung disease
Publicado: (2018)

Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
por: Yamakawa, Hideaki, et al.
Publicado: (2021)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Children’s Interstitial and Diffuse Lung Diseases (ChILD) in 2020
por: Ferraro, Valentina Agnese, et al.
Publicado: (2020)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry—The EXCITING-ILD Registry
por: Kreuter, Michael, et al.
Publicado: (2015)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Respiratory disease burden in India: Indian chest society SWORD survey
por: Singh, Virendra, et al.
Publicado: (2018)

An unusual case of interstitial lung disease: Revisiting peribronchiolar metaplasia interstitial lung disease (PBM‐ILD)
por: Jung, Flora, et al.
Publicado: (2023)

Surfactant Metabolism Dysfunction and Childhood Interstitial Lung Disease (chILD)
por: McFetridge, Lynne, et al.
Publicado: (2009)

Hypersensitivity pneumonitis: Clinical manifestations – Prospective data from the interstitial lung disease-India registry
por: Singh, Sheetu, et al.
Publicado: (2019)

ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease
por: Fujii, Hiroaki, et al.
Publicado: (2023)

ILDgenDB: integrated genetic knowledge resource for interstitial lung diseases (ILDs)
por: Mishra, Smriti, et al.
Publicado: (2018)

Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians
por: Althobiani, Malik, et al.
Publicado: (2021)

An Unusual Association of Idiopathic Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) With Interstitial Lung Disease (ILD)
por: Saha, Shubhashis, et al.
Publicado: (2023)

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Jee, Adelle S., et al.
Publicado: (2017)

Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
por: Shumar, John N., et al.
Publicado: (2021)

High resolution computed tomography patterns in interstitial lung disease (ILD): prevalence and prognosis
por: Almeida, Renata Fragomeni, et al.
Publicado: (2020)

Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
por: Westerink, Lotte, et al.
Publicado: (2022)

Selected respiratory research work from NAPCON 2019
por: Sharma, Bharat Bhushan, et al.
Publicado: (2019)

Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry
por: Behr, Juergen, et al.
Publicado: (2023)

Asthma-like peak flow variability in various lung diseases
por: Singh, Virendra, et al.
Publicado: (2012)

Implementation of the Needs Assessment Tool for patients with interstitial lung disease (NAT:ILD): facilitators and barriers
por: Reigada, C, et al.
Publicado: (2017)

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
por: Spagnolo, Paolo, et al.
Publicado: (2021)

Decision-Making Strategy for the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)
por: Yamakawa, Hideaki, et al.
Publicado: (2021)

Care patterns of patients with chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype
por: Nili, Mona, et al.
Publicado: (2022)

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
por: Guiot, Julien, et al.
Publicado: (2022)

Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class I-Related Chain A (MICA) as Markers of ILD
por: Furukawa, Hiroshi, et al.
Publicado: (2015)

Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis
por: Patel, Avignat S., et al.
Publicado: (2023)

Impact of ILD-Specific Therapies on Perioperative Course in Patients with Progressive Interstitial Lung Disease Undergoing Lung Transplantation
por: Munker, Dieter, et al.
Publicado: (2023)

Towards the Essence of Progressiveness: Bringing Progressive Fibrosing Interstitial Lung Disease (PF-ILD) to the Next Stage
por: De Sadeleer, Laurens J., et al.
Publicado: (2020)

Understanding post-COVID-19 interstitial lung disease (ILD): a new fibroinflammatory disease entity
por: Mehta, Puja, et al.
Publicado: (2022)

Response to “Noninvasive determinants of pulmonary hypertension (PH) in interstitial lung disease (ILD)” by Joseph et al.
por: Parikh, Raj, et al.
Publicado: (2023)

Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses
por: Fields, Aislin, et al.
Publicado: (2023)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2020)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
por: Yoo, Hongseok, et al.
Publicado: (2022)

Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg)
por: Krauss, Ekaterina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7c5foun9r1q3vqiggjgse9b2bb